More PRNewswire
View Older Stories View Newer Stories-
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
-
Regal Rexnord Corporation to Host Fourth Quarter 2024 Earnings Conference Call on Thursday, February 6, 2025
-
Powerfleet to Present at the 27th Annual Needham Growth Conference
-
Serna Bio Announces Scientific Advisory Board
-
Sen-Jam Pharmaceutical Announces Planned AI Initiative for Molecule Repurposing
-
Immorta Bio to Present New Data on SenoVax™ and StemCell Revivify™ at Biotech Showcase 2025
-
Cmbio® Acquires Eagle Genomics' Assets to Enhance Multi-Omics Software and AI/ML capabilities of its Digital Biology Platform.
-
A Blockbuster Year for Concierge Medicine: Specialdocs Reports a Record 26 Physician-Clients Launched Practices in 2024
-
General Counsel Åsa Thunman to leave Sandvik
-
Spectral Capital Welcomes Aaron Christensen as Chief Revenue Officer to Lead Global Expansion of Vogon Cloud Solutions
-
Net Lease Office Properties Announces Sales of Five Office Properties Totaling $43 Million
-
Alphyn to Present at Upcoming Investor Conferences
-
Opera to Participate in Upcoming Investor Conference
-
Global Times: Nearly 80% of foreign respondents show confidence in China's development prospect in first survey on China's international image
-
FINAL DAYS OF DSF: LAST CHANCE TO EXPERIENCE THE EPIC 30TH EDITION IN ITS CLOSING WEEKEND
-
Global Competition Launches to Drug 'Undruggable' Cancer Target
-
Five Star Franchising brands named 2025 Top Franchises by Franchise Business Review
-
Aircastle Announces Third Quarter 2024 Results
-
Marengo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis
-
Empowering the Next Generation: Aurora Announces German Internship Program
-
Neogen Announces Preliminary¹ Second-Quarter 2025 Results
-
Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
-
AKTIS ONCOLOGY TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
-
Branford Castle Acquires Eastern Dental Management, a Leading Dental Services Organization, from Staple Street Capital
-
Cipia unveils ADAS capabilities for Cipia-FS10, redefining its fleet safety offering with a 360° Road and Driver Monitoring Solution
-
The Tel-Aviv Stock Exchange Reports Buyback of the Company's shares from Manikay Fund
-
Introducing Pairzon's Next Generation Media Mix Modeling (MMM) Tool
-
The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease
-
Top Food Trends of 2025 That Will Have You Choosing Beef
-
Fintech nsave launches investment platform, offering people from distressed economies protection from inflation with compliant and safe investments abroad
-
Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
-
ez1099 2024 Edition Tax Preparation Software for 2025 Tax Season Is Available for Electronic Filing
-
BD Names Pamela Spikner as Chief Accounting Officer and Controller
-
INTEGRA ANNOUNCES LEADERSHIP TRANSITION
-
From the Tax Law Offices of David W. Klasing - What If You Didn't File Required IRS FBARs?
-
Delta Air Lines Announces December Quarter and Full Year 2024 Financial Results
-
Quarterhill Awarded High-Speed Weigh-In-Motion Prescreening Contract in Belgium
-
Xenia Hotels & Resorts Announces Timing of Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
OneMain Holdings Announces Date of Fourth Quarter 2024 Earnings Release and Conference Call
-
Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China
-
Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
-
16 Press Releases You Need to See This Week
-
Maple Leaf Foods Lays Groundwork for Transformational Year Ahead
-
ChipMOS EXPECTS 6.3% FULL YEAR 2024 REVENUE GROWTH, WITH A 5.4% YoY DECEMBER 2024 REVENUE DECLINE AND A 5.7% YoY 4Q24 REVENUE DECLINE
-
Ouro Medicines Launches to Define the Future of Treatment for People with Immune-Mediated Diseases
-
Maple Leaf Foods Increases Quarterly Dividend by 9% and announces First Quarter Distribution
-
Sensory Pioneer AAC Technologies Unveils Comprehensive Advanced Solutions at CES 2025, Raising the Bar for the Industry
-
China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly
-
Market Eyes "Crypto President" Inauguration as BTC Tumbles at $100K: Bybit and Block Scholes Analysis
